Thomas Catinazzo

Chief Financial OfficeratRelay Therapeutics· In proxies 2021–2025

Pay in FY2025-64% from the year before · Relay Therapeutics stock +105.3% the same year

Thomas Catinazzo was paid $1.6M in FY2025 (Dec), down 64%. Relay Therapeutics stock rose 105.3% that year.

Pay$100 in the stock at the end of FY20 → $20

Pay is from the Summary Compensation Table of each Relay Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

Relay TherapeuticsPublic company · 5 yr
- Chief Financial Officer2021 – Present · 5 yrStock in role -58%

Roles come from the proxy statements of each company.

Activity

Pay
Relay Therapeutics CFO pay fell 64% to $1.6M. The stock rose 105% in FY2025 (Dec).
DEF 14AApr 28, 2026
Pay
Relay Therapeutics CFO pay fell 16% to $4.4M. The stock fell 63% in FY2024 (Dec).
DEF 14AApr 23, 2025
Pay
Relay Therapeutics CFO pay rose 112% to $5.2M. The stock fell 26% in FY2023 (Dec).
DEF 14AApr 23, 2024
Pay
Relay Therapeutics CFO pay rose 34% to $2.5M. The stock fell 51% in FY2022 (Dec).
DEF 14AApr 23, 2024

For the press:Download CSV Download PNG How to use our data

Two people shown as one, or a wrong number?